Summary. Islet-cell antibodies have been reported to be of predictive value for the future development of Type I (insulin-dependent) diabetes in first degree relatives of diabetic patients with the risk increasing in these subjects with the islet-cell antibodies titre. However, very little is known about islet-cell antibodies in background populations. Sera (n = 8363) from schoolchildren (6-17 years) in the French background population were screened for the presence of islet-cell antibodies by the indirect immunofluorescence technique. Islet-cell antibodies greater than 4.5 Juvenile Diabetes Foundation units were found in 150 sera (prevalence rate 1.8 %; 95 % confidence interval 1.5-2.1%). Only 17 sera demonstrated islet-cell antibody titre > 24 JDF units. No particular feature was found to be significantly different between islet-cell antibody-positive and islet-cell antibodynegative children (age, family history of diabetes, fasting plasma glucose, insulin autoantibodies). A second blood sample was obtained from 80 of 150 islet-cell antibody positive children after a mean interval of 8 months. Only 11 sera became < 4.5 JDF units with islet-cell antibody titres being stable in the remaining sera, including the high-titre positive sera ( > 24 JDF units). HLA-DQB typing was performed by restriction mapping techniques in 80 islet-cell antibody-positive, in 93 islet-cell antibody-negative and in 213 Type 1 diabetic children. The distribution of the susceptibility alleles (DQB1-Asp57-negative) was not significantly different between islet-cell antibody-positive and islet-cell antibodynegative children. This survey has identified a low islet-cell antibody prevalence rate in French schoolchildren, among whom the incidence rate of Type 1 diabetes is one of the lowest in Europe. The genetic study indicates that part of this group of children are not prone to developing the disease. The predictive value of islet-cell antibodies in normal children will be estimated during the long-term follow-up of this population.
More than 15 years ago islet-cell autoantibodies (ICA) were identified in sera from patients with recent onset Type I (insulin-dependent) diabetes mellitus [1] . The presence of these antibodies is one of the indications that Type i diabetes is an autoimmune disease. ICA are also important for the description of the long latent period preceding the diagnosis of the overt disease [2] , and several surveys have evaluated the predictive value of ICA which appear to be currently the best marker for the development of the disease in first degree relatives of Type 1 diabetic patients [3] . The overall risk has been estimated to be 8 % per patient-year, but the predictive value increases considerably with ICA titres [4] [5] [6] .
Although the risk of Type I diabetes is increased in first degree relatives, familial cases represent the minority of the patients. Most of the cases are sporadic and much knowledge is to be gained from the markers of the prediabetic phase in this group of patients.
Several studies have reported on prevalence rates of ICA in background populations, examining samples of various sizes (Table 1) [7] [8] [9] [10] [11] [12] . Geographic variations have been observed and some authors have speculated on the possible relationship between prevalence of ICA in the background population and the incidence of the disease [13] [14] [15] [16] [17] [18] . However, no study has yet focused on other autoimmune markers or on genetic risk markers, especially on HLA typing of ICA-positive subjects.
We have therefore designed a survey aiming at evaluating the prevalence rate in schoolchildren from the French background population. It is noteworthy that the incidence rate of Type i diabetes is one of the lowest in Europe [19] . Another aim was to describe the group of ICA-positive children in terms of clinical history, other markers of autoimmunity and HLA typing, comparing ICA-positive subjects to age-matched ICA-negative subjects and to a group of diabetic children. Results of ICA positivity and information on the research programme were given to the family practitioners responsible for the follow-up of these children. Out of 150 ICA-positive children 80 are participating and a second blood collection was obtained in these children. Sera and ceils were used for the subsequent ICA determination and HLA-DQ typing and measurement of glycated haemoglobin.
Approval from the Ethics Committee of the Paris VII University School of Medicine was obtained for the study design.
Type I diabetic children (n = 213) were randomly recruited from the patients attending the paediatric diabetes clinic at the Robert Debr6 hospital (Paris) and were used for comparison in the HLA-DQ study only.
Analytical methods
ICA were detected by the indirect immtmofluorescence method using a single human blood group O pancreas [20] . Results were determined as the last serum dilution containing ICA positivity; each titre was then converted into JDF units as recommended by the 3 ~ International Workshop on Standardization of ICA [21] . The end point titre of the standard JDF serum was 1: 64. The detection limit for an undiluted positive serum was 4.5 JDF units. Coefficients of variation for day to day precision were 15% and 24% at 48 and 4.5 JDF units respectively. Each positive serum was read by two independent observe1~; in case of discrepancy a third observer was consulted, and the sample reanalysed in another series. Three hundred negative sera were randomly selected and assayed in a separate run, several months apart, to assess the consistency of negativity.
Insulin autoantibodies (IAA) were determined in the first 2,000 sera, arbitrarily chosen for this part of the study. They were measured by the radioimmmlobinding method using human iodihated insulin and serum stripping by acid precipitation and charcoal extraction. The detailed procedure has been previously described [22] . A serum was considered IAA positive if the total and the displaceable insulin bindings were simultaneously above 3 SD of the reference means (2.9 % and 1.13 % respectively).
Anti-microsomal thyroid auto-antibodies were tested according to the method described by Doniach et al. [23] .
Glycated haemoglobin was measured by ion exchange high performance chromatography on an automated chromatograph (Diamat, Biorad, Richmond Calif., USA) with a mean reference value of 5.1 + 0.3 % (inter-assay coefficient of variation = 1.2% for HbAI~ at 5%).
HLA typing was performed by the identification of susceptibility alleles at the DQ region. DNA was extracted from peripheral blood leucocytes. Exon 2 of the HLA-DQB1 genes were amplified using the polymerase chain reaction (PCR). The polymorphism of DQB1 locus was studied by differential restriction mapping as already described [24] . This method allows the identification of 11 alleles. Seven alleles coding for a residue different from an aspartate at position 57 of the flchain are defined as susceptibility alleles and four allelles coding for an aspartate residue are defined as protective alleles.
Statistical analysis
ICA titres and JDF units were log2 transformed before calculation and the results are given for geometric means _+ SD. Chi-square analysis was used for comparisons of frequencies. All calculations were performed with the Fastat computer program (Systat Inc., Evanston IlL, USA).
Results

ICA prevalence rates
ICA positivity was found in 150 sera, with a prevalence rate of 1.79 % (95 % confidence limits: 1.50-2.08 % ). No significant difference was observed in the prevalence rates according to age and sex ( Table 2 ). The prevalence data according to the sera titres are indicated in Table 3 . The majority of the sera were weakly positive (undiluted positive sera: 49%). Seventeen sera showed _>24 JDF units. There was no significant variation in ICA titres with age.
Characteristics of the ICA-positive children
ICA-positive and negative children did not differ in age (means = 11.5 + 2.4 and tl,3 _+ 2.2 years, respectively). One female was already a known diabetic patient in the ICA-positive group but none in the ICA-negative group.
Age (years) (Fig. 1) . Among the 150 ICA-positive subjects, nine demonstrated plasma glucose levels outside the reference interval for age: five were lower, and four were greater including the diabetic child. In these nine children ICA titres were _< 8 JDF units, except in the diabetic child (24 JDF units) and in the child with the lowest blood glucose level (2.88 mmol/1; 24 JDF units).
Follow-up of the ICA positive children HLA-DQB typing
A second blood sample was obtained in 80 children after a mean interval of 8.3 months (range: 5-15 months). These 80 children did not differ from the remaining 70 ICApositive children in terms of age, family history of diabetes and distribution of ICA titres (Fig. 2) . Eleven sera became negative (which were previously undiluted positive) and the rest of the sera remained stable within an interval of two doubling dilutions; two sera gained more than two titre dilutions between the first 579 and the second sample. One serum was both ICA-and IAA-positive on the first sample but lost IAA-positivity on the second one. None of the 80 sera were positive for anti-microsomal thyroid autoantibodies. All HbA~c values were normal (range: 4.0-5.3 %).
One 7-year-old boy has become diabetic 10 months after the first screening. ICA were 42 JDF units on the first sample, and an identical titre was found 7 months later. At the second blood sampling (3 months before the diagnosis of diabetes) HbA~c was normal. IAA were found negative at the two time points. This boy carried two susceptibility alleles at the HLA-DQB region.
None of the 70 children in whom a second blood sample could not be collected have become diabetic; this information was gathered using a questionaire mailed to the family practitioners of these children with a mean follow-up of 10 months.
Insulin autoantibodies (IAA )
All the ICA-positive sera and the first 2,000 ICA-negative sera were screened for the presence of IAA. The prevalence rate was 1.15% (95% confidence limits: 0.6-1.6 %) among 2,000 sera. The mean total insulin binding A second sample was obtained from 16 of 22 IAA-positive children, 10 months apart. Two children were both ICA-and IAA-positive at the first determination and were stable for ICA-positivity on the second determination, but one serum only remained IAA-positive. The other 14 sera became IAA-negative and remained ICAnegative. 
Discussion
Identification of ICA in serum from first degree relatives of Type 1 diabetic patients is an important marker of the prediabetic phase preceding the overt diagnosis of the disease as attested by almost all the family studies [3, 5, 6, 25] . However, it must be emphasized that familial cases are a minority and that the large majority of new cases are sporadic. In a recent survey in France, it has been found that only 7 % of the incident cases developed in already affected famlies [26] . It seems reasonable therefore to create screening programmes for people from background, low-risk populations since this is where most cases will occur. Table 4 . Distribution of the allelic combinations at the D QB 1-HLA region in ICA positive, ICA negative and in Type 1 (insulin-dependent) diabetic children Allelic ICA-positive ICA-negative Diabetic children combinations (n = 80) (n = 93) (n = 213) DQB1 n % n % n % position 57 NA/NA  27  34  18  30  183  86  NA/Asp  35  44  41  44  28  13  Asp/Asp  18  22  24  26  2  1 NA, amino-acid different from aspartic acid at position 57; ICA, islet-cell antibodies ICA screening in children from background population is a difficult and laborious task. This goal has been achieved in few countries and large variations in the ICA prevalence rates have been reported between countries ranging from 4.1% in Finland to 0.35 % in Spain. Interestingly enough, similar geographical disparities have been observed in incidence rates of the disease (under 15 years of age) in these very countries.
Before any speculation on the meaning of these data, several pittfalls in screening methodology and ICA assay are to be examined: the size of the population sample and the sensitivity and precision of the ICA assay. It has been shown that the ICA detection limit is highly variable between laboratories [27] mainly due to the quality or the nature of the pancreas used as substrate [28] . As the low titres sera ( < 15-20 JDF units) represent the largest component of ICA positive sera in all of these studies, decreasing the detection limit would increase the overall number of positive sera and therefore increase the prevalence rates. If we look at the numbers of sera containing high titres of ICA ( > 20 JDF units) the prevalence rates fall to very low values in each country: none in Spain, 0.15 % in the Netherlands, 0.26 % in Florida, 1.8 % in Sweden and 2.9 % in Finland. In our population 11% of ICA-positive children demonstrated a high titre ( _> 24 JDF units). ICAtitres were found remarkably stable over time. More strikingly, the 11 patients with titres > 24 JDF units remained elevated. ICA-positivity scarcely disappeared, except in the very low titre ICA-positive sera, as already reported in siblings [29] .
ICA are identified in the majority of Type i diabetic children at the time of diagnosis [1] . However, despite sensitive assays about 20 % of the children are persistently found to be ICA-negative at the onset of the disease [30] . 1CA have been recognized in 3-13 % of the siblings of Type 1 diabetic patients, according to the assay and the number of subjects. Interestingly, all these studies identified the large majority of ICA-positive relatives at the time of the first screening, and very few "converters" have been observed during the follow-up period. Two factors interfere strongly with the relative risk attributed to the presence of ICA: titre and age. The risk of developing Type 1 diabetes within 8 years becomes much higher if ICA are > 20-40 JDF units [4, 6] , and if age at initial testing is _< 10 years [5] . In children from background population, three studies clearly indicate that ICA-positivity may figure as a risk marker for the disease. In the studies from Florida and Finland, it was indicated that persisting high titres of ICA confined a far higher risk. In our survey, one child became diabetic within i year and exhibited persisting ICA at 42 JDF units. Conversely, we found a poor informative value ascribed to the presence of IAA-positivity, as already reported in some family studies [6, 31] .
In each country the number of children found to be ICA-positive was much greater than expected from calculations on incidence rates of Type i diabetes. If the number of ICA-positive children is large not all these children will progress to developing the disease. ICA-positivity could be a sign of non-specific immune activation by exogeneous factors such as viruses [32] . The remarkable stability of ICA titres observed in this study and the lack of antithyroid antibodies, as already reported [33] , do not argue in favour of this hypothesis.
It has been shown that Type i diabetes develops among HLA identical or haplo-identical siblings to the affected proband and that the risk is increased if the shared phenotypes are DR3 or DR4 [34] . Results in the literature are rather conflicting about ICA-positivity and HLA status. Vexiau et al. reported that there was no association in siblings between ICA-positivity and HLA identity [35] . In the studies from Oxford and Lyon, ICA-positivity was not associated with a given haplotype. DR antigens are in linkage desequilibrium with restricted phenotypes at the DQ region [36] . Todd et al. have shown that DQB1 alleles encoding an amino-acid different than an aspartic acid at position 57 of the/3 chain determined a high relative risk for Type 1 diabetes [37] . Using these techniques, Lipton et al. have recently shown that the distribution of the DQB genetic markers did not differ among ICA-negative and positive siblings of diabetic children. On the other hand, the 18ICA-positive siblings who developed Type 1 diabetes carried the susceptibility alleles at the DQB region [38] . Genetic studies in ICA-positive schoolchildren are rare. They have been carried out only in Florida in the 16 high titre ICA-positive children: 31.3 % (vs 2.5% in control subjects) were DR3/4 heterozygotes and 6.3 % lacked these antigens. In Germany, high levels of ICA were found to be associated with the non-aspartate-57 DQB 1 alleles in children from the background population [39] . We found no significant difference in the distribution of the susceptibility alleles between ICA-positive and -negative children. If we consider the high titre ICA-positive children, three of them (33 %) carried two major susceptibility alleles ('0201 and/or *0302-data not shown).
This study has identified a large group of children exhibiting at least one risk marker for Type 1 diabetes. Two pieces of evidence suggest that this group is heteroge-581 neous. Firstly, the number of individuals is greater than expected from calculations based upon incidence data of the overt disease in France. Secondly, 22 % of the children carry an HLA genotype rarely found in diabetic children. In twins, it has been recently reported that ICA-positivity and glucose intolerance under oral glucose load could be seen in the second twin at the time of diagnosis of the twin proband [40] . These abnormalities were transient, consistent with the hypothesis that ICA could be the witness of insulitis, and that some individuals are able to recover from these attacks, not developing diabetes. A longer follow-up of this population will be necessary to better define the risk of developing Type 1 diabetes previously ascribed to ICA in high-risk groups.
